These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 364564)

  • 41. [The uses of sequential analysis for statistical evaluation of some criteria in a double-blind clinical trial].
    Pavelka K; Kanková D; Vojtísek O
    Fysiatr Revmatol Vestn; 1975 Dec; 53(6):326-8. PubMed ID: 765249
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical evaluation in rheumatology of a non-steroid anti-inflammatory agent, niflumic acid, as compared with other anti-inflammatory drugs].
    Menarini C; Ferri S; Lanzarini AM; Alianti M
    Reumatismo; 1971; 23(6):318-39. PubMed ID: 5293571
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effect of niflumic acid on chronic rheumatoid arthritis].
    Shichikawa K; Onoda T
    Ryumachi; 1976 May; 16(2):199-211. PubMed ID: 785616
    [No Abstract]   [Full Text] [Related]  

  • 44. [Determination of efficacy of proquazone in chronic rheumatoid arthritis].
    Shichikawa K; Azuma T; Ogawa N
    Ryumachi; 1982 Jun; 22(3):275-83. PubMed ID: 6750811
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of patients with rheumatoid arthritis with DMARD (disease modifying anti-rheumatic drugs)].
    Halberg P
    Ugeskr Laeger; 1984 Jul; 146(27):1995-2000. PubMed ID: 6440327
    [No Abstract]   [Full Text] [Related]  

  • 46. A double-blind comparison of phenylbutazone and suxibuzone, a prodrug of phenylbutazone, in rheumatoid arthritis.
    Mizushima Y; Shiokawa Y; Honma M; Kageyama T
    Int J Tissue React; 1983; 5(1):35-9. PubMed ID: 6345427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Orgotein in the treatment of rheumatoid arthritis.
    Menander-Huber KB
    Eur J Rheumatol Inflamm; 1981; 4(2):201-11. PubMed ID: 7044787
    [No Abstract]   [Full Text] [Related]  

  • 48. Rheumatoid arthritis--anti-inflammatory drugs.
    Paulus HE
    Clin Rheum Dis; 1983 Dec; 9(3):571-80. PubMed ID: 6360513
    [No Abstract]   [Full Text] [Related]  

  • 49. [Evaluation of the therapeutic action of flufenamic acid in patients with chronic polyarthritis in a double blind study].
    Mathies H; Eichhorn M
    Med Monatsschr; 1967 Nov; 21(11):510-6. PubMed ID: 4893773
    [No Abstract]   [Full Text] [Related]  

  • 50. A double-blind study comparing benoxaprofen, aspirin, and benoxaprofen plus aspirin in patients with rheumatoid arthritis.
    Ridolfo AS; Ashbrook EM; Schmid GE; Vogel JA; Rockhold FW; Offen WW
    Eur J Rheumatol Inflamm; 1982; 5(2):239-45. PubMed ID: 7044799
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic efficacy of bufexamac in rheumatoid arthritis: a double-blind comparison with indomethacin.
    Pavelka K; Wagenhauser F
    Curr Ther Res Clin Exp; 1970 Feb; 12(2):69-72. PubMed ID: 4984321
    [No Abstract]   [Full Text] [Related]  

  • 52. [Results of a controlled clinical double blind study between isobutylphenylpropionic acid and indomethacin].
    Colombo B; Chérié Ligniére G; Carrabba M
    Minerva Med; 1973; 64(48):2522-6. PubMed ID: 4580155
    [No Abstract]   [Full Text] [Related]  

  • 53. [Drug evaluation on naproxen for chronic rheumatoid arthritis].
    Shiogawa Y; Okada T; Sakuma A
    Ryumachi; 1974 Jul; 14(2):141-54. PubMed ID: 4616374
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical evaluation of drug efficacy by the double blind method in medicine (author's transl)].
    Shimizu N
    Nihon Naika Gakkai Zasshi; 1976 Jan; 65(1):15-29. PubMed ID: 9459
    [No Abstract]   [Full Text] [Related]  

  • 55. [Pharmacodynamics and adverse effects of modern nonsteroid anti-inflammatory agents].
    Guobis G; Iushenaite Ia
    Ter Arkh; 1981; 53(7):142-51. PubMed ID: 6457407
    [No Abstract]   [Full Text] [Related]  

  • 56. A controlled trial of tiaprofenic acid against indomethacin in patients with rheumatoid arthritis.
    Nichol FE; Daymond TJ; Pandit NA; Sheldon P; Swannell AJ
    Int J Clin Pharmacol Res; 1985; 5(3):157-9. PubMed ID: 3894257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Jaundice caused by niflumic acid (Inflaryl)].
    van Berge Henegouwen GP; Hartman AP; Werre JM; Brandt KH
    Ned Tijdschr Geneeskd; 1974 Aug; 118(32):1229-32. PubMed ID: 4849020
    [No Abstract]   [Full Text] [Related]  

  • 58. [Glucamethacin in rheumatology: clinical study].
    Colombo B; Carrabba M; Paresce E; Benetello V
    Reumatismo; 1977; 28(2):106-10. PubMed ID: 325615
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparative evaluation of carprofen and indomethacin in rheumatoid patients.
    Lussier A; Rouleau L; Caron M; Tétreault L
    Int J Clin Pharmacol Ther Toxicol; 1980 Nov; 18(11):482-7. PubMed ID: 7009441
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparative trial by double-blind method of a niflumic acid derivative and oxyphenbutazone in pediatric O. R. L].
    Traissac L; Roche JC
    Rev Laryngol Otol Rhinol (Bord); 1979; 100(1-2):151-61. PubMed ID: 379941
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.